ClinicalTrials.gov
ClinicalTrials.gov Menu

Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00929019
Recruitment Status : Terminated (slow accrual)
First Posted : June 26, 2009
Last Update Posted : December 8, 2016
Sponsor:
Collaborator:
Rotterdam Eye Hospital
Information provided by (Responsible Party):
Radboud University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 2016
  Actual Study Completion Date : April 2016